GlassScriptPhysician profile
Anna Lydia Lahatte
NPI 1225692320
$2,353.44
in general payments reported to CMS, 2019-2025
20 companies · $929 in 2025
The $929 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $35.27 · 2023: $619 · 2024: $770 · 2025: $929.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,318.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $455.27 | 2023-2025 | Lifevest |
| Amgen INC. | $402.84 | 2023-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $355.29 | 2023-2025 | Wainua, Farxiga, Andexxa |
| Boston Scientific Corporation | $231.78 | 2025 | Watchman Flx, Rhythmia Mapping System |
| Novartis Pharmaceuticals Corporation | $175.81 | 2023-2025 | |
| Abbott Laboratories | $168.69 | 2023-2025 | Aveir, Thoratec Heartmate 3 Lvas Implant Kit |
| Edwards Lifesciences Corporation | $153.13 | 2023-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Pfizer INC. | $83.31 | 2023-2024 | |
| Actelion Pharmaceuticals US, INC. | $53.25 | 2022-2023 | Opsumit, Uptravi |
| Janssen Pharmaceuticals, INC | $47.82 | 2024 | Xarelto |
| Merck Sharp & Dohme LLC | $36.08 | 2024 | Verquvo |
| Sanofi-Aventis U.S. LLC | $32.41 | 2023-2024 | |
| Cvrx, INC. | $28.52 | 2025 | Barostim Neo System |
| Convatec INC. | $20.94 | 2024 | |
| Chiesi USA, INC. | $20.47 | 2024 | Kengreal |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $19.97 | 2025 | |
| Vital Connect, INC | $19.87 | 2023 | Vitalpatch Rtm |
| Heartflow, INC. | $17.86 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.30 | 2023 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $13.83 | 2023 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Lahatte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.